Table 4.
Treatment with lipid lowering drugs and control of dyslipidaemia among participants with a history of coronary heart disease
| Age 16-44
|
Age 45-64
|
Age 65-75
|
Age 16-75
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Men (n=13) | Women (n=9) | Men (n=133) | Women (n=62) | Men (n=131) | Women (n=92) | Men (n=277) | Women (n=163) | ||||
| No taking treatment or with total cholesterol concentration >5 mmol/l | 10 | 6 | 117 | 55 | 108 | 89 | 235 | 150 | |||
| % (No) treated* | 30 (3) | 0 (0) | 41 (48) | 36 (20) | 23 (25) | 20 (18) | 32 (76) | 25 (38) | |||
| % (No) controlled*† | 10 (1) | 0 (0) | 16 (19) | 11 (6) | 15 (16) | 9 (8) | 15 (36) | 9 (14) | |||
*
Among those with total cholesterol concentration >5 mmol/l or taking treatment.
†
Total cholesterol concentration <5 mmol/l.